Multiple Myeloma: Available Therapies and Causes of Drug Resistance

Multiple myeloma (MM) is the second most common blood cancer. Treatments for MM include corticosteroids, alkylating agents, anthracyclines, proteasome inhibitors, immunomodulatory drugs, histone deacetylase inhibitors and monoclonal antibodies. Survival outcomes have improved substantially due to th...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinto, Vanessa, Bergantim, Rui, Caires, Hugo R., Seca, Hugo, Guimarães, José E., Vasconcelos, M. Helena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072128/
https://www.ncbi.nlm.nih.gov/pubmed/32050631
http://dx.doi.org/10.3390/cancers12020407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072128/
https://www.ncbi.nlm.nih.gov/pubmed/32050631
http://dx.doi.org/10.3390/cancers12020407

Ejemplares similares